Molecular basis for the subtype discrimination of the estrogen receptor-β-selective ligand, diarylpropionitrile

Molecular Endocrinology

Volumn 17, Issue 2, 2003, Pages 247-258

  Sun, Jun ^a   Baudry, Jerome ^b   Katzenellenbogen, John A ^b   Katzenellenbogen, Benita S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIGAND; NITRILE; PHENOL; PROPIONITRILE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CHIMERA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DNA HELIX; ENANTIOMER; HORMONE RESPONSE; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR MODEL; MUTANT; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; BINDING SITES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; LIGANDS; METHIONINE; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MUTATION; NITRILES; PROTEIN CONFORMATION; RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; THREONINE; TUMOR CELLS, CULTURED;

EID: 0037312834     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0341     Document Type: Article

References (51)

1. Nilsson S, Gustafsson JA 2002 Biological role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol 37:1-28
2. McEwen BS, Alves SE 1999 Estrogen actions in the central nervous system. Endocr Rev 20:279-307
3. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PGV, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA 2000 Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55:163-195
4. Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M, Chambon P 1985 Cloning of the human estrogen-receptor cDNA. Proc Natl Acad Sci USA 82:7889-7893
5. Mosselman S, Polman J, Dijkema R 1996 ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
6. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
7. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870
8. McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS 1998 Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras. Endocrinology 139:4513-4522
9. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson JA, Nilsson S 1998 Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol Pharmacol 54:105-112
10. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS 2002 Characterization of the biological roles of the estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology 143:4172-4177
11. Katzenellenbogen BS, Sun J, Harrington WR, Kraichely DM, Ganessunker D, Katzenellenbogen JA 2001 Structure-function relationships in estrogen receptors and the characterization of novel selective estrogen receptor modulators (SERMs) with unique pharmacological profiles. Proceedings of the NIH Workshop on SERMs. Ann NY Acad Sci 949:6-15
12. Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA, Katzenellenbogen BS 1999 Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β. Endocrinology 140:800-804
13. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2000 Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-α-selective agonists. J Med Chem 43:4934-4947
14. Sun J, Huang YR, Harrington WR, Sheng SB, Katzenellenbogen JA, Katzenellenbogen BS 2002 Antagonists selective for estrogen receptor α. Endocrinology 143:941-947
15. Mortensen DS, Rodriguez AL, Carlson KE, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2001 Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor α. J Med Chem 44:3838-3848
16. Mortensen DS, Rodriguez AL, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2001 Furans with basic side chains: synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor α. Bioorg Med Chem Lett 11:2521-2524
17. Stauffer SR, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2000 Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction. Bioorg Med Chem 8:1293-1316
18. Larrea F, Garcia-Becerra R, Lemus AE, Garcia GA, Perez-Palacios G, Jackson KJ, Coleman KM, Dace R, Smith CL, Cooney AJ 2001 A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER α. Endocrinology 142:3791-3799
19. Henke BR, Drewry DH, Jones SA, Stewart EL, Weaver SL, Wiethe RW 2001 2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor. Bioorg Med Chem Lett 11:1939-1942
20. Lin X, Huebner V 2000 Non-steroidal ligands for steroid hormone receptors. Curr Opin Drug Disc 3:383-398
21. Ghosh U, Ganessunker D, Sattigeri J, Carlson KE, Mortensen DJ, Katzenellenbogen BS, Katzenellenbogen JA, Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes. Bioorg Med Chem, in press
22. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
23. Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA 1999 Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetra-hydrochrysenes. J Med Chem 42:2456-2468
24. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL 2002 Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 9:359-364
25. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230-4251
26. Stemmer WPC 1994 Rapid evolution of a protein in-vitro by DNA shuffling. Nature 370:389-391
27. Stemmer WPC 1994 DNA shuffling by random fragmentation and reassembly-in-vitro recombination for molecular evolution. Proc Natl Acad Sci USA 91:10747-10751
28. Zhang JH, Dawes G, Stemmer WPC 1997 Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening. Proc Natl Acad Sci USA 94:4504-4509
29. Giver L, Gershenson A, Freskgard PO, Arnold FH 1998 Directed evolution of a thermostable esterase. Proc Natl Acad Sci USA 95:12809-12813
30. Zhao HM, Arnold FH 1997 Functional and nonfunctional mutations distinguished by random recombination of homologous genes. Proc Natl Acad Sci USA 94:7997-8000
31. Hansson LO, Mannervik B 2000 Use of chimeras generated by DNA shuffling: probing structure-function relationships among glutathione transferases. Methods Enzymol 328:463-477
32. Coco WM, Levinson WE, Crist MJ, Hektor HJ, Darzins A, Pienkos PT, Squires CH, Monticello DJ 2001 DNA shuffling method for generating highly recombined genes and evolved enzymes. Nat Biotechnol 19:354-359
33. Pike ACW, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JK, Carlquist M 1999 Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618
34. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758
35. Kumar V, Green S, Staub A, Chambon P 1986 Localization of the oestradiol-binding and putative DNA binding domains of the human oestrogen receptor. EMBO J 5:2231-2236
36. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51:941-951
37. McInerney EM, Katzenellenbogen BS 1996 Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J Biol Chem 271:24172-24178
38. Kraus WL, McInerney EM, Katzenellenbogen BS 1995 Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci USA 92:12314-12318
39. Wrenn CK, Katzenellenbogen BS 1993 Structure-function analysis of the hormone-binding domain of the human estrogen-receptor by region-specific mutagenesis and phenotypic screening in yeast. J Biol Chem 268:24089-24098
40. Ekena K, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS 1996 Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding. J Biol Chem 271:20053-20059
41. Ekena K, Katzenellenbogen JA, Katzenellenbogen BS 1998 Determinants of ligand specificity of estrogen receptor-α: estrogen vs. androgen discrimination. J Biol Chem 273:693-699
42. Montano MM, Müller V, Trobaugh A, Katzenellenbogen BS 1995 The carboxyl-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol Endocrinol 9:814-825
43. Benhamou B, Garcia T, Lerouge T, Vergezac A, Gofflo D, Bigogne C, Chambon P, Gronemeyer H 1992 A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 255:206-209
44. Vivat V, Gofflo D, Garcia T, Wurtz JM, Bourguet W, Philibert D, Gronemeyer H 1997 Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities. J Mol Endocrinol 18:147-160
45. Ekena K, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS 1997 Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens. J Biol Chem 272:5069-5075
46. Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek Jr SR, Weinmann R, Einspahr HM 2001 Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98:4904-4909
47. Cronet P, Petersen JF, Folmer R, Blomberg N, Sjoblom K, Karlsson U, Lindstedt EL, Bamberg K 2001 Structure of the PPAR-α and -γ, ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure (Camb) 9:699-706
48. Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe Jr RT, McKee DD, Moore JT, Willson TM 2001 Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 98:13919-13924
49. Klaholz BP, Mitschler A, Moras D 2000 Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. J Mol Biol 302:155-170
50. Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR 2001 The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292:2329-2333
51. Sun J, Katzenellenbogen JA, Zhao H, Katzenellenbogen BS, DNA shuffling method for generating estrogen receptor α and β chimeras in yeast. Biotechniques, in press